Literature DB >> 35382395

Bilateral calcinosis cutis of orbital walls in CREST syndrome.

Hadi Ghadimi1, Mojgan Nikdel1, Bahram Eshraghi1.   

Abstract

Purpose: To describe a patient with systemic sclerosis who presented with subcutaneous yellow-white nodules on her lateral orbital rims.
Methods: Case report.
Results: A 53-year-old female was referred for management of subcutaneous firm nodules on her lateral orbital rims. She was known to have CREST (calcification, Raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) syndrome, a limited variant of systemic sclerosis. Her drug history included diltiazem, captopril, aspirin, and prednisolone. There were bilateral multiple immobile yellow-white subcutaneous nodules with firm consistency, a few of which were in close proximity of periorbital skin. She was scheduled for surgical resection of the lesions and following tissue dissection, the calcified foci were removed. The incisions healed with some delay but the final postoperative follow-up at third month showed satisfactory appearance.
Conclusion: Dystrophic calcinosis cutis occurs in approximately one-fourth of patients with systemic sclerosis (scleroderma), particularly in those with the limited variant or CREST syndrome. The most frequently involved sites are the extremities. Occasionally, calcinosis involves the trunk or head, but involvement of bony orbital walls is extremely rare. Surgical excision can be considered for treatment of discrete foci of calcinosis cutis.
© The Author(s) 2019.

Entities:  

Keywords:  CREST syndrome; Calcinosis cutis; dystrophic calcification; scleroderma; systemic sclerosis

Year:  2019        PMID: 35382395      PMCID: PMC8922648          DOI: 10.1177/2397198318819383

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  9 in total

1.  Orbital bone and soft tissue calcification in CREST syndrome.

Authors:  Olivia C Morris; David H Verity; Philip J Luthert; Geoffrey E Rose
Journal:  Clin Exp Ophthalmol       Date:  2010-07       Impact factor: 4.207

Review 2.  Calcinosis cutis: part I. Diagnostic pathway.

Authors:  Nadine Reiter; Laila El-Shabrawi; Bernd Leinweber; Andrea Berghold; Elisabeth Aberer
Journal:  J Am Acad Dermatol       Date:  2011-07       Impact factor: 11.527

3.  Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996-2009.

Authors:  Samuel J Balin; David A Wetter; Louise K Andersen; Mark D P Davis
Journal:  Arch Dermatol       Date:  2011-12-19

Review 4.  Calcinosis in rheumatic diseases.

Authors:  Nina Boulman; Gleb Slobodin; Michael Rozenbaum; Itzhak Rosner
Journal:  Semin Arthritis Rheum       Date:  2005-06       Impact factor: 5.532

5.  Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline.

Authors:  L P Robertson; R W Marshall; P Hickling
Journal:  Ann Rheum Dis       Date:  2003-03       Impact factor: 19.103

Review 6.  Calcifying disorders of the skin.

Authors:  J S Walsh; J A Fairley
Journal:  J Am Acad Dermatol       Date:  1995-11       Impact factor: 11.527

7.  Facial subcutaneous calcinosis and mandibular resorption in systemic sclerosis: a case report.

Authors:  E Alpöz; H Cankaya; P Güneri
Journal:  Dentomaxillofac Radiol       Date:  2007-03       Impact factor: 2.419

Review 8.  Low dose warfarin treatment for calcinosis in patients with systemic sclerosis.

Authors:  T Cukierman; E Elinav; M Korem; T Chajek-Shaul
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

9.  Surgical treatment of calcinosis cutis in the upper extremity.

Authors:  B C Mendelson; R L Linscheid; J H Dobyns; S A Muller
Journal:  J Hand Surg Am       Date:  1977-07       Impact factor: 2.230

  9 in total
  1 in total

Review 1.  Calcinosis in systemic sclerosis.

Authors:  Srijana Davuluri; Christian Lood; Lorinda Chung
Journal:  Curr Opin Rheumatol       Date:  2022-08-19       Impact factor: 4.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.